全國服務咨詢熱線:
15921799099
15921799099
全部多肽類型
•多肽混合庫
•多肽文庫
•單條多肽
•多肽（微）陣列
靈活定制參數
•規模：微克級至克級
•純度：粗品至 95% 以上
•用途：僅用于研究（RUO）、符合 GLP 規范、預 GMP / 臨床級
•常規合成長度：2?50 個氨基酸
•包裝載體：西林瓶、試管架、載玻片、多孔板、膜材
種類繁多的修飾方式
•磷酸化修飾
•非天然及稀有氨基酸修飾
•同位素標記多肽
•熒光標記
•生物素化
•環化修飾
•生物偶聯
•更多其他修飾
為何選擇 JPT？
•全球技術支持團隊
•二十余年多肽合成行業經驗
•嚴苛的環境、健康與倫理標準
•先進技術、頂尖設備與專業技術團隊
商品化多肽產品
適用于免疫學、蛋白質組學、糖尿病、阿爾茨海默病等多個領域
抗原多肽與多肽混合庫
•500 余種 PepMix 多肽混合庫，數千種單一抗原多肽
•實驗對照多肽：例如 CEFX、pp65、Ova
•病毒抗原：EB 病毒、人類皰疹病毒、新冠病毒、人類冠狀病毒、巨細胞病毒、人乳頭瘤病毒、水痘?帶狀皰疹病毒等
•細菌抗原：結核分枝桿菌等
•基因載體：人腺病毒、黑猩猩腺病毒、腺相關病毒等
•腫瘤抗原：MUC1、PRAME/OIP4、NY?ESO?1、MART?1、Wt1 等
單種多肽
•β?淀粉樣多肽
•細胞穿透肽
•化妝品多肽（DRPA）
•糖尿病相關多肽
•水凝膠形成多肽
•多肽親和標簽
•放射性配體與放射增敏劑
•轉導增強肽
試劑盒與陣列
•定量蛋白質組學參考試劑盒、標準品及對照品
•酶底物套裝
•玻璃基多肽微陣列
商品化多肽產品數量：2000 + 種
更多產品信息，請聯系中國區域代理商：上海起發實驗試劑有限公司
（注：本文內容基于品牌公開資料及行業常規信息整理，具體以品牌信息文檔為準。）
??JPT Peptide Technologies GmbH熱賣產品
貨號 | 品名 | 規格 |
PM-CEFX-2 | CEFX Ultra SuperStim Pool | 15nmol(approx.25ug)/peptideforstimulationof2,5x108cells |
PM-EBV-LMP2 | PepMix™ EBV (LMP2) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-OIP4 | PepMix Human (Prame/OIP4) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-PP65-1 | PepMix™ HCMVA （pp65） | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-CEFX-1 | CEFX Ultra SuperStim Pool | 15nmol(approx.25ug)/peptide |
PM-PD-L1 | PepMix Human (PD-L1) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-VZV-gE | PepMix™ VZV (gE) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-CEF-S-3 | CEF Pool (standard) 15nmol>90％ | 15nmol(approx.25ug)/peptideforstimulationof2,5x108cells |
PM-IE1 | PepMix™ HCMVA (IE-1) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-PP65-2 | PepMix™ HCMVA (pp65) (>90％) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-CEF-E-3 | CEF Pool (extended) | 15nmol(approx.25ug)/peptideforstimulationof2,5x108cells |
PM-EBV-BZLF1 | PepMix™ EBV (BZLF1) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-HIV-ENV | PepMix HIV-1 (ENV) Ultra | 25ug(approx.15nmol)/peptide |
PM-HPV16-E6 | PepMix™ HPV 16 （E6） | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-HPV16-E7 | PepMix™ HPV 16 (E7) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-MOG | PepMix Human (MOG) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-CEFT-3 | CEFT Pool (15 nmol, >90%) | 15nmol(approx.25ug)/peptideforstimulationof2,5x108cells |
PM-CEFT-MHC-II-1 | CEFT MHC-II Pool | 15nmol(approx.25ug)/peptideforstimulationof2,5x108cells |
PM-CEFX-3 | CEFX Ultra SuperStim Pool MHC-II Subset (15 nmol, >70%) | 15nmol(approx.25ug)/peptideforstimulationof2,5x108cells |
PM-CyCMV-UL55 | PepMix CyCMV (GP-UL55) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-EBV-BMRF1 | PepMix™ EBV (BMRF1) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-EBV-EBNA1 | PepMix™ EBV (EBNA1) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-EBV-EBNA3a | PepMix™ EBV (EBNA3a) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-EBV-EBNA3b | PepMix™ EBV (EBNA3b) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-EBV-EBNA3c | PepMixEBV（EBNA3c） | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-HBV-CPULTRA | PepMix™ HBV (Capsid Protein) Ultra | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-HRSVB-FGF0 | PepMix™ HRSVB (Fusion Glycoprotein F0) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-HSV2-gC | PepMix HSV2 (gC) | 25ug(approx.15nmol)/peptide |
PM-HSV2-gD | PepMix HSV2 (gD) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-INFA-HAIndo | PepMix™ Influenza A (HA/Indonesia (H5N1)) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-INFB-NAAUT21 | PepMix™ Influenza B (NA/H0N0/Austria/2021) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-MYCTU-AG85B | PepMix M. tuberculosis (Ag85B) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-MYCTU-CFP10 | PepMix M. tuberculosis (CFP-10) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-MYCTU-ESAT6 | PepMix M. tuberculosis (ESAT-6) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-WCPV-S-RBD-1 | PepMix™ SARS-CoV-2 (S-RBD) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-ACTS | PepMix™ Human (Actin) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-CEA | PepMix™ Human (CEA) | 25ug(approx.15nmol) |
PM-CEF-E-1 | CEF Pool (extended) | 15nmol(approx.25ug)/peptideforstimulationof2,5x108cells |
PM-CEF-S-4 | CEF Pool (standard) | 120nmol/peptide |
PM-CEFSX-2 | CEFSX Ultra SuperStim Pool | 15nmol(approx.25ug)/peptide |
PM-CEFT-MHC-II-2 | CEFT MHC-II Pool | 120nmol(approx.200ug)/peptide |
PM-CEFT-MHC-II-3 | CEFT MHC-II Pool | 15nmol(approx.25ug)/peptide |
PM-CEFT-MHC-II-4 | CEFT MHC-II Pool | 120nmol/peptide |
PM-CEFX-4 | CEFX Ultra SuperStim Pool MHC-I Subset | 15nmol(approx.25ug)/peptideforstimulationof2,5x108cells |
PM-CLD6 | PepMix™ Human (Claudin-6) * Protein ID: P56747 | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-EBV-BARF1 | PepMix™ EBV (BARF1) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-EBV-BMLF1 | PepMix™ EBV (BMLF1) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-EBV-BRLF1 | PepMix™ EBV (BRLF1) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-EBV-EBNA-LP | PepMix™ EBV (EBNA-LP) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-EBV-EBNA2 | PepMix™ EBV (EBNA2) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-EBV-GP350/GP340 | PepMix EBV (GP350/GP340) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-EBV-LMP1 | PepMixEBV（LMP1） | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-HBV-LEPULTRA | PepMix™ HBV (LEP) Ultra | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-HIV-GAG | PepMix™ HIV-1 (GAG) Ultra | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-HIV-POL | PepMix HIV-1 (POL) Ultra | 25ug(approx.15nmol)/peptide |
PM-HPV16-E1 | PepMix HPV16 (E1) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-HRSVA-FGF0 | PepMix HRSVA (Fusion Glycoprotein F0) | 25ug(approx.15nmol)/peptide |
PM-HSV2-E3 | PepMix™ HSV2 (E3 ICP0)(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) | 25ug |
PM-HSV2-gB | PepMix HSV2 (gB) | 25ug(approx.15nmol)/peptide |
PM-INF-M1U01-1 | PepMix Influenza A (M1) Ultra | 25ug(approx.15nmol)/peptide |
PM-INFA_NA | PepMix Influenza A (Neuroamidase /California (H1N1) *C7FH14 | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-INFA-HADAR21-1 | PepMix Influenza A (HA/H3N2/Darwin/2021) | 25ug(approx.15nmol)/peptide |
PM-INFA-HADAR21-2 | PepMix™ Influenza A (HA/H3N2/Darwin/2021) | 25ug |
PM-INFA-HAGUA23 | PepMix Influenza A (HA/H5N1/Guanajuato/2023) | 25ug(approx.15nmol)/peptide |
PM-INFA-NADAR21 | PepMix Influenza A (NA/H3N2/Darwin/2021) | 25ug(approx.15nmol)/peptide |
PM-INFA-NPPR | PepMix™ Influenza A (NP/Puerto Rico/8/1934 H1N1) | 25 ug (approx. 15 nmol) |
PM-INFB-HAAUT21-1 | PepMix™ Influenza B (HA/H0N0/Austria/2021) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-INFB-HAPHU13-1 | PepMix™ Influenza B (HA/H0N0/Phuket/2013) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-KKLC1 | PepMix™ Human (KKLC1) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-MAGEA3 | PepMix™ Human (MAGEA3) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-MAGEA4 | PepMix Human (MAGEA4) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-MAGEC1 | PepMix™ Human (MAGEC1) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-MEASW-HGP | PepMix Measles virus (Hemagglutinin glycoprotein) | 25ug(approx.15nmol)/peptide |
PM-P53 | PepMix Human (P53) | 25ug(approx.15nmol)/peptide |
PM-Pan-CMVselect-1 | PepMix™ Pan-CMV Select | 15nmol(approx.25ug)/peptideforstimulationof2,5x108cells |
PM-Pan-EBVselect-1 | PepMix Pan-EBV Select | 15nmol(approx.25ug)/peptide |
PM-Pan-PXVselect-1 | PepMix Pan-Poxviridae Select | 15nmol(approx.25ug)/peptide |
PM-SARS2-SMUT09-1 | PepMix SARS-CoV-2 (Spike B.1.1.529 / BA.2 / Omicron) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-Survivin | PepMix Human (Survivin) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-TARP | PepMix™ Human (TCRgamma alternate reading frame protein TARP) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-WCPV-S-1 | PepMix™ SARS-CoV-2 (Spike Glycoprotein) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-WCPV-S-2 | PepMix™ SARS-CoV-2 (Spike Glycoprotein) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-WCPV-S-SU1-1 | PepMix™ SARS-CoV-2 (Spike Glycoprotein SUB1) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
SP-CAT-001-1 | Lysine Peptide | 10mg |
SP-CAT-002-1 | Cysteine Peptide | 10mg |
SP-MHCI-0005-3 | Antigen Peptide CMV pp65 - HLA-A*0201 (NLVPMVATV) | 10mg |
SP-MHCI-0006-1 | Antigen Peptide MART-1 (Leu26) - HLA-A*0201 (ELAGIGILTV) | 50ug |
SP-MHCI-0118-1 | Antigen Peptide Envelope glycoprotein H-2 Ld (SPSYVYHQF) | 50ug |
Custom-peptide | Sequence: WDCLDNRIGRRQCVKL,Purity: >70% | 1mg |
OF-23338 | Customized PepMix | ea |
OF-31957 | Gedys-PA-4509 SpikeTides L - peptides | 24pc. |
PM-AAV2-VP1 | PepMix AAV2 (Capsid Protein VP1) | 25ug(approx.15nmol)/peptide |
PM-AAV5-CP | PepMix AAV5 (Capsid Protein) | 25ug(approx.15nmol)/peptide |
PM-AAV8-CP | PepMix™ AAV8 (capsid protein) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-ASPFU-CRF1 | PepMix™ Aspergillus fumigatus (Probable glycosidase crf1) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-BKV-LTA | PepMix BKV (large T antigen) | 25ug(approx.15nmol)/peptide |
PM-BKV-VP1 | PepMix BKV (capsid protein VP1) | 25ug(approx.15nmol)/peptide |
PM-C-EBV-1 | PepMix Collection EBV (2x1ug/peptide) | 2xaliquotsofeachpeptidepool(1ug/peptide/pool) |
PM-C-SARS2-WSP-2 | PepMix Collection SARS-CoV-2 Wuhan Structural Proteins | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-C1 | PepMix™ Human (HLA classI Ig-like C1 type domain) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
電話
微信
當前位置：
地址：上海浦東川沙鎮川沙路6619號上海起發實驗試劑有限公司
郵箱：xs1@78bio.com
傳真：021-50724961